相似文献
1
Lyme disease.
Semin Dermatol. 1993 Dec;12(4):357-62.
2
Antimicrobial susceptibility of Borrelia burgdorferi sensu lato: what we know, what we don't know, and what we need to know.
Wien Klin Wochenschr. 2006 Nov;118(21-22):659-68. doi: 10.1007/s00508-006-0693-z.
3
[Treatment of Borrelia burgdorferi infection].
Enferm Infecc Microbiol Clin. 1991 Jan;9(1):52-4.
4
[Erythema chronicum migrans].
Rev Prat. 2013 Feb;63(2):178.
5
Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans.
Antimicrob Agents Chemother. 1995 Mar;39(3):661-7. doi: 10.1128/AAC.39.3.661.
6
Lyme disease.
Dermatol Clin. 1992 Oct;10(4):763-75.
7
Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis.
Lancet. 1997 Feb 8;349(9049):399. doi: 10.1016/S0140-6736(97)80017-7.
8
[Lyme borreliosis: How should erythema migrans be treated in pregnant women?].
Dtsch Med Wochenschr. 2009 Nov;134(46):2354. doi: 10.1055/s-0029-1242694. Epub 2009 Nov 5.
9
Lyme disease. A general survey.
Int J Dermatol. 1990 Jan-Feb;29(1):1-8. doi: 10.1111/j.1365-4362.1990.tb03745.x.
10
Risk of culture-confirmed borrelial persistence in patients treated for erythema migrans and possible mechanisms of resistance.
Int J Med Microbiol. 2006 May;296 Suppl 40:233-41. doi: 10.1016/j.ijmm.2006.01.028. Epub 2006 Mar 10.
引用本文的文献
1
Clarithromycin in treatment of early Lyme disease: a pilot study.
Antimicrob Agents Chemother. 1996 Feb;40(2):468-9. doi: 10.1128/AAC.40.2.468.
Zotero 插件